# Oral Dosage Form New Animal Drugs; Milbemycin Oxime
> **Food and Drug Administration** · Final rule. · Published 1995-09-28 · Effective 1995-09-28 · 60 FR 50096
## Document
- **Document number:** 95-24160
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 60 FR 50096
- **CFR reference:** 21 CFR 520
- **Publication date:** 1995-09-28
- **Effective date:** 1995-09-28
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Ciba-Geigy Animal Health, Ciba-Geigy Corp. The supplemental NADA provides for the use of milbemycin oxime tablets in puppies 4 weeks of age or greater and 2 pounds (lb) of body weight or greater for the prevention of heartworm disease, control of adult hookworm infections, and removal and control of adult roundworm and whipworm infections.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1995/09/28/95-24160/oral-dosage-form-new-animal-drugs-milbemycin-oxime)
---
*AI Analytics · CC0 1.0*